Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
36.48
+0.18 (0.50%)
Sep 24, 2026, 3:18 PM AST
TADAWUL:4017 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, TADAWUL:4017 stock has a consensus rating of "Hold" and an average price target of SAR 40.40. The average 1-year stock price forecast is 10.75% higher than the current stock price, while the lowest is SAR 36.00 (-1.32%) and the highest is SAR 44.10 (+20.89%).
Price Target: SAR 40.40 (+10.75%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4017 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
3.47B
from 3.09B
Increased by 12.27%
Revenue Next Year
4.15B
from 3.47B
Increased by 19.57%
EPS This Year
1.12
from 1.26
Decreased by -11.11%
EPS Next Year
1.22
from 1.12
Increased by 8.49%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.